Legal Representation
Attorney
Glenn A. Gundersen
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 25, 2009 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Aug 25, 2009 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jan 27, 2009 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 27, 2009 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 27, 2009 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 22, 2009 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 2, 2008 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Dec 2, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 18, 2008 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Oct 23, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
pharmaceutical drug development services
First Use Anywhere:
Jun 22, 2008
First Use in Commerce:
Jun 22, 2008
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"RISK MANAGEMENT"